5Tello-Montoliu A,Marín F,Roldán V,et al.A multimarker risk stratification approach to non-ST elevation acute coronary syndrome:implications of troponin T,CRP,NT pro-BNP and fibrin D-dimer levels[J].J Intern Med,2007,262(6):651-658.
6Nafasi L,Rahmani R,Shafiee A,et al.Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction[J].Curr Med Res Opin,2014,30(3):381-386.
5Pasceri V,Patti G,Nusca A,et al.Randomised trial of atorvastain forreduction of myocardial damage during coronary intervention:results from the ARMYDA(Atorvastatin for Reduction ofmyocardial Damage during Angioplasty)study[J].Circulation,2004,110(6):674-678.
6Giuseppe P,Vincenzo P,Giuseppe C,et al.Atorvastatin PretreatmentImproves Outcomes in Patients With Acute Coronary SyndromesUndergoing Early Percutaneous Coronary Intervention[J].Am JCardiol,2007,49(8):1272-1278.
7Danesh J,Wheeler JG,Hirschfield GM,et al.C-reactive protein andother circulatingmarkers of inflammation in the prediction ofcoronary heart disease[J].N Engl J Med,2004,(350):1387-1397.
8Briguori C,Viseonti G,Foeaeeio A,et al.Novel APProaehes forPreventing or Limiting Events(NaPles)ⅡTrial Impact of a SingleHigh Loading Dose of Atorvastatin on Periprocedural MyocardialInfarction[J].JAm Coll Cardiol,2009,54(23):2157-2163.
9Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med, 1993, 328(10) 680 684.
10Weaver WD, Simes RJ, Betriu A, et al. Comparison of prima ry coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction., a quantitative review. JAMA, 1997, 278(23) = 2093 2098.
